Niklas Ekman
European Medicines Agency(NL)Finnish Medicines Agency Fimea(FI)
Publications by Year
Research Areas
Biosimilars and Bioanalytical Methods, Pharmaceutical Economics and Policy, Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials
Most-Cited Works
- → Biosimilars: what clinicians should know(2012)345 cited
- → Biosimilars—why terminology matters(2011)214 cited
- → In support of the European Union biosimilar framework(2012)38 cited
- → Biosimilar regulation in the EU(2015)38 cited
- → Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience(2022)35 cited
- → A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies(2022)26 cited
- → Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?(2023)21 cited
- → Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016(2016)15 cited
- → The Tailored Biosimilar Approach: Expectations and Requirements(2025)9 cited
- → Reducing healthcare costs and building trust in biosimilar medicines(2016)6 cited